Albright Charles 4
4 · Editas Medicine, Inc. · Filed Oct 16, 2020
Insider Transaction Report
Form 4
Albright Charles
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-10-15$31.39/sh−3,000$94,170→ 25,135 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.
- [F2]This transaction was executed in multiple trades at prices ranging from $30.88 to $31.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.